Skip Navigation



Journal of the National Cancer Institute Advance Access published online on October 27, 2009
JNCI Journal of the National Cancer Institute, doi:10.1093/jnci/djp374
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by de Kok, I. M. C. M.
Right arrow Articles by Habbema, J. D. F.
PubMed
Right arrow Articles by de Kok, I. M. C. M.
Right arrow Articles by Habbema, J. D. F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press 2009.

CORRESPONDENCE

Response: Re: Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands

Inge M. C. M. de Kok, Marjolein van Ballegooijen, J. DIK F. Habbema

Affiliation of authors: Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, the Netherlands (IMCMdK, MvB, DJDFH)

Correspondence to: Inge M. C. M. de Kok, MSc, Department of Public Health, Erasmus MC, University Medical Center, PO Box 2040, 3000 CA Rotterdam, the Netherlands (e-mail: i.dekok@erasmusmc.nl).

The first 10% of the full text of this article appears below.

We welcome the comments of Coupé et al. They highlight an important issue in cost-effectiveness analysis, namely the choice of discount rates. . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?